FDA Approved First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
On Nov. 14, 2024, the U.S. Food and Drug Administration approved PTC Therapeutics’ Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated…
Agriculture | Biotechnology | Diagnostics | Environmental | EPA | FDA | Infectious Disease | Life Science News
FDA and EPA Announced First Registered Pre-Harvest Agricultural Water Treatment
On Nov. 4, 2024, the U.S. Food and Drug Administration (FDA), in collaboration with the Environmental Protection Agency…
Biotechnology | Chemical | FDA | Life Science News | NIH | Radiology | Therapeutics
HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity
On Oct. 28, 2024, HOPO Therapeutics announced that it has been awarded a contract valued at up to…
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
FLUBLOK® (Influenza Vaccine) U.S. label updated with one of Sanofi’s largest flu vaccine safety studies in pregnant individuals
On Oct. 16, 2024, The U.S. Food and Drug Administration (FDA) announced it had updated the label for…
RedHill Biopharma Secured U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZIâ„¢ (marstacimab-hncq)…
FDA Approved Arctic apple for commercialization
On Oct. 8, 2024, Okanagan Specialty Fruits® (OSF), the developer and grower behind the innovative Arctic® apple varieties, announced that its…
FDA Approved Cologuard Plus Test, Setting New Benchmark in Colorectal Cancer Screening
On Oct. 4, 2024, Exact Sciences announced the U.S. Food and Drug Administration (FDA) had approved the Cologuard…
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy
On Oct. 2, 2024, a study from the GBD Tobacco Forecasting Collaborators reported that by accelerating the decline…
FDA | Life Science News | NIH
FDA Modernization Efforts for Establishing a Unified Human Foods Program launched
On Oct. 1, 2024, the U.S. Food and Drug Administration (FDA) announced that the unified Human Foods Program,…
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
FDA Approved Nasal Spray Influenza Vaccine for at home use
On Sept. 20, 2024, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is…
FDA authorized first OTC hearing aid software to be used in Apple’s AirPods Pro
On Sep. 12, 2024, the the U.S. Food and Drug Administration (FDA) authorized the first over-the-counter (OTC) hearing…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
FDA Approved Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
FDA Approved ‘First Gene Therapy’ to Treat Adults with Metastatic Synovial Sarcoma
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
FDA Permited Marketing of First Point-of-Care Hepatitis C RNA Test
On Jun. 27, 2024, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
FDA Expanded Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
U.S. FDA Approved CAPVAXIVEâ„¢ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVEâ„¢ (Pneumococcal…
COVID-19 | FDA | Life Science News | Therapeutics | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S Beginning in Fall 2024
On Jun. 14, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA EUA
On Jun. 10, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S. Beginning in Fall 2024
On June 5, 2024, the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee announced that it had…
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
Roche announced FDA approval of HPV self-collection solutions in the U.S. , expanding screening to help eliminate cervical cancer
On May 14, 2024, Roche announced the U.S. FDA approval of its human papillomavirus (HPV) self-collection solution, one…
Labcorp received FDA Emergency Use Authorization for Mpox PCR test home collection kit
On Apr. 10, 2024, LabCorp announced announced that the U.S. Food and Drug Administration (FDA) had granted Emergency…
Otsuka and Click Therapeutics announce FDA clearance of Rejoyn, first prescription digital therapeutic for MDD
On Apr. 1, 2024, Otsuka Pharmaceutica and Click Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
Roche received FDA approval for the first molecular test to screen for malaria in blood donors
On Mar. 26, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) had approved the cobasï¾®…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration the FDA issued an emergency use authorization for…